Abstract
Alzheimer’s disease (AD) is one of the top public health challenges facing the Western world and developing countries due to ever-increasing aging population [1]. There is, however, no effective means to prevent or to treat AD. There have been more than 100 drug trials targeting specific AD pathogenic mechanisms since 1998, all of which have failed [2]. Since AD is a complex disease involving multiple interrelating pathogenic mechanisms, redirecting therapeutic strategies to simultaneously target multiple pathogenic mechanisms may increase the likelihood of success.
| Original language | English |
|---|---|
| Title of host publication | Protein Folding Disorders of the Central Nervous System |
| Publisher | World Scientific Publishing Co. |
| Pages | 281-304 |
| Number of pages | 24 |
| ISBN (Electronic) | 9789813222960 |
| State | Published - 1 Jan 2017 |
Fingerprint
Dive into the research topics of 'Role of the Microbiome in Polyphenol Metabolite-Mediated Attenuation of β-amyloid and tau Protein Misfolding in Alzheimer’s Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver